Dan Brennan
Stock Analyst at TD Cowen
(3.65)
# 575
Out of 5,182 analysts
127
Total ratings
45.92%
Success rate
8.38%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Maintains: Buy | $13 → $14 | $9.44 | +48.31% | 8 | Apr 29, 2026 | |
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $114.52 | +37.09% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $3.06 | +226.80% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $87.60 | +54.11% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $36.79 | +16.88% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $22.43 | -15.29% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $86.68 | +43.05% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $469.21 | +45.56% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $135.78 | +3.11% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $175.15 | +54.15% | 7 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $12 | $7.96 | +50.75% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $2.06 | +239.81% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $307.12 | +26.99% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.80 | +87.50% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.27 | +5.12% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $18.47 | +73.25% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $65.38 | +68.25% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.73 | -32.98% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $55.00 | +34.55% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $207.28 | -15.57% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $165.78 | +50.80% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $48.11 | +6.01% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $11.08 | +405.42% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $133.58 | +308.74% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.60 | +837.50% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $112.85 | +105.58% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,267.07 | -30.55% | 3 | Oct 7, 2020 |
NeoGenomics
Apr 29, 2026
Maintains: Buy
Price Target: $13 → $14
Current: $9.44
Upside: +48.31%
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $114.52
Upside: +37.09%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $3.06
Upside: +226.80%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $87.60
Upside: +54.11%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $36.79
Upside: +16.88%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $22.43
Upside: -15.29%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $86.68
Upside: +43.05%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $469.21
Upside: +45.56%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $135.78
Upside: +3.11%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $175.15
Upside: +54.15%
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $7.96
Upside: +50.75%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $2.06
Upside: +239.81%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $307.12
Upside: +26.99%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.80
Upside: +87.50%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $14.27
Upside: +5.12%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $18.47
Upside: +73.25%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $65.38
Upside: +68.25%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.73
Upside: -32.98%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $55.00
Upside: +34.55%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $207.28
Upside: -15.57%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $165.78
Upside: +50.80%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $48.11
Upside: +6.01%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $11.08
Upside: +405.42%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $133.58
Upside: +308.74%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.60
Upside: +837.50%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $112.85
Upside: +105.58%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,267.07
Upside: -30.55%